Electrocardiographic Markers of Sudden Death

Cardiology Clinics

Volumn 24, Issue 3, 2006, Pages 453-469

  Ott, Peter ^a   Marcus, Frank I ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARRHYTHMOGENESIS; AUTOPSY; BRUGADA SYNDROME; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; PRIORITY JOURNAL; QT INTERVAL; REVIEW; RISK ASSESSMENT; SUDDEN DEATH; WOLFF PARKINSON WHITE SYNDROME;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; HUMANS;

EID: 33747881711     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2006.03.004     Document Type: Review

References (78)

1. Pratt C.M., Grennway P.S., Schoenfield M.H., et al. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation 93 (1996) 519-524
2. Zheng Z.J., Croft J.B., Giles W.H., et al. Sudden death in the United States 1989-1998. Circulation 104 (2001) 2158-2163
3. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden death: epidemiology, transient risk and intervention assessment. Ann Intern Med 119 (1993) 1187-1197
4. de Vreede-Swagemakers J.J., Gorgels A.P.M., Dubois-Arbouw W.I., et al. Out-of hospital cardiac arrest in the 1990s: a population based study in the Maastricht area on incidence, characteristics and survival. J Am Coll Cardiol 30 (1997) 1500-1505
5. Moss A.J., Zareba W., Hall J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
6. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
7. Kuller L., Cooper M., and Perper J. Epidemiology of sudden death. Arch Intern Med 129 (1972) 714-719
8. Newman W.P., Strong J.P., and Johnson W.D. Community pathology of atherosclerosis and coronary artery disease in New Orleans. Morphologic findings in young black and white men. Lab Invest 44 (1981) 496-501
9. Kudenchuck P.J., Cobb L.A., Greene H.L., et al. Late outcome of survivors of out of hospital cardiac arrest with left ventricular functions >50% and without significant coronary arterial narrowing. Am J Cardiol 67 (1991) 704-708
10. Freedman R.A., Swerdlow C.D., Soderholm-Difatte V., et al. Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest. Am J Cardiol 61 (1988) 578-582
11. Gorgeles A.P.M., Gijsbers C., de Vreede-Swagemakers J., et al. Out of hospital cardiac arrest-the relevance of heart failure: the Maastricht Circulatory Arrest Registry. Eur Heart J 24 (2003) 1204-1209
12. Maggioni A.P., Zuanetti G., Franzosi M.G., et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation 87 (1993) 312-322
13. Cairns J.A., Connolly S.J., Roberts R., et al. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 349 (1997) 675-682
14. Zimetbaum P.J., Buxton A.E., Batsford W., et al. Electrocardiographic predictors of arrhythmic death and total mortality in the Multicenter Unsustained Tachycardia Trial. Circulation 110 (2004) 766-769
15. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolocatone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 (1999) 709-717
16. MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure. Lancet 353 (1999) 2001-2007
17. Luu M., Stevenson W.G., Stevenson L.W., et al. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80 (1989) 1675-1680
18. Dec G.W., and Fuster V. Medical progress: idiopathic dilated cardiomyopathy. N Engl J Med 331 (1993) 1564
19. Teerlink J.R., Jalaluddin M., Anderson S., et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict in increased risk of sudden death. Circulation 101 (2000) 40-46
20. Schwartz K., Carrier L., Guicheney P., et al. Molecular basis for familial cardiomyopathies. Circulation 91 (1995) 532-540
21. Yamaguchi H., Ishimura T., Nishiyama S., et al. Hypertrophic non-obstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 44 (1979) 401-412
22. Frank S., and Braunwald E. Idiopathic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history. Circulation 37 (1968) 759
23. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
24. Maron B.J., Casey S.A., Poliac L.C., et al. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 281 (1999) 650-655
25. Maron B.J., Shirani J., Poliac L.C., et al. Sudden death in young competitive athletes. Clinical, demographic and pathological profiles. JAMA 276 (1996) 199-204
26. Montgomery J.V., Harris K.M., Casey S.A., et al. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 96 (2005) 270-275
27. McKenna W.J., Borggrefe M., England D., et al. The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation 66 (1982) 1233
28. Erickson M.J., Sonnenberg B., Woo A., et al. Long term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 39 (2002) 638-645
29. Marcus F.I., and Fontaine G. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review. PACE 18 (1995) 1298-1314
30. Thienne G., Nava A., Corrado D., et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318 (1988) 129-133
31. Rampazzo N., Nava A., Malacrida S., et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 71 (2002) 1200-1206
32. Tiso N., Stephan D.A., Nava A., et al. Identification of mutation in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10 (2001) 189-194
33. McKenna W.J., Thienne G., Nava A., et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy: task force of the working group myocardial and pericardial disease of the European Society of Cardiology and the Scientific Council on Cardiomyopathies of the international society and federation of cardiology. Br Heart J 71 (1994) 215-218
34. Marcus F.I. Prevalence of T wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol 95 (2005) 1070-1071
35. Fontaine G., Umemura J., DiDonna P., et al. La duree des complexes QRS dans la dysplasie ventriculaire droite arythmogene. Un noveau marqueur diagnostique non-invasif. Ann Cardiol Angeiol (Paris) 42 (1993) 399-405
36. Nasir K., Bomma C., Tandri H., et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity. A need to broaden diagnostic criteria. Circulation 110 (2004) 1527-1534
37. Turrini P., Corrado D., Basso C., et al. Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy. Ann Noninvasive Electrocardiol 8 (2003) 161-169
38. Peters S., Peters H., and Thierfelder L. Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in right ventricular dysplasia-cardiomyopathy. Int J Cardiol 71 (1999) 243-250
39. Jervell A., and Lange-Nielsen F. Congenital deaf mutism, functional heart disease with prolonged QT interval and sudden death. Am Heart J 54 (1957) 59-68
40. Moss A.J., and Robinson J. Clincial features of idiopathic long QT syndrome. Circulation 85 suppl I (1992) II40-II44
41. Vincent G.M., Timothy K.W., Leppert M., et al. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 327 (1992) 846-852
42. Schwartz P.J., Moss A.J., Vincent G.M., et al. Diagnostic criteria for the long QT syndrome: an update. Circulation 88 (1993) 782-784
43. Moss A.J., Zareba W., Benhorin J., et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 92 (1995) 2929-2934
44. Zareba W., Moss A.J., Schwartz P.J., et al. Influence of the genotype on the clinical course of the long QT syndrome. N Engl J Med 339 (1998) 960-965
45. Schwartz P.J., Priori S.G., Spazzolini C., et al. Genotype-phenotype correlation in the long QT syndrome. Gene specific triggers for life-threatening arrhythmias. Circulation 103 (2001) 89-95
46. Ackerman M.J., Khositseth A., Tester D., et al. Epinephrine induced QT interval prolongation: a gene specific paradoxical response in congenital long QT syndrome. Majo Clin Proc 77 (2002) 413-421
47. Khosiseth A., Hejlik J., Shen W.K., et al. Epinephrine induced T wave notching in congenital long QT syndrome. Heart Rhythm 2 (2005) 141-146
48. Priori S.G., Schwartz P.J., Napolitano C., et al. Risk stratification in the long-QT syndrome. N Engl J Med 348 (2003) 1866-1874
49. Zareba W., Moss A.J., Vessie C., et al. T wave alternans in idiopathic long QT syndrome. J Am Coll Cardiol 23 (1994) 1541-1546
50. Malfatto G., Beria G., Sala S., Bonazzi O., et al. Quantitative analysis of T wave abnormalities and their prognostic implications in the long QT syndrome. J Am Coll Cardiol 23 (1994) 296-301
51. Gussak I., Brugada P., Brugada J., et al. Idiopathic short QT interval: a new clinical syndrome?. Cardiology 94 (2000) 99-102
52. Gaita F., Giustetto C., Bianchi F., et al. Short QT syndrome. A familial cause of sudden death. Circulation 108 (2003) 965-970
53. Bellocq C., Ginneken G.C., Bezzina C., et al. Mutation in the KCNQ1 Gene leading to the short QT interval syndrome. Circulation 109 (2004) 2394-2397
54. Giusetto C., Wolpert C., Anttonnen O.M., et al. Clinical presentation of the patients with short QT syndrome. Heart Rhythm 2 II (2005) S61
55. Gaita F., Giustetto C., Bianchi F., et al. Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 43 (2004) 1494-1499
56. Brugada P., and Brugada J. Right bundle branch block persistent ST segment elevation and sudden death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 20 (1992) 1391-1396
57. Chen Q., Kirsch G.E., Zhang D., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 (1998) 293-295
58. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 12 (2001) 268-272
59. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome. Report of the second consensus conference. Heart Rhyhtm 2 (2005) 429-440
60. Miyazaki T., Mitamura H., Miyoshi S., et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 27 (1996) 1061-1070
61. Fujiki A., Usui M., Nagasawa H., et al. ST segment elevation in the right precordial leads induced with class Ic antiarrhythmic drugs: insight into the mechanism of Brugada syndrome. J Cardiovasc Electrophysiol 10 (1999) 214-218
62. Gasparini M., Priori S., Mantica M., et al. Flecainide test in Brugada syndrome: a reproducible but risky tool. PACE 26 pt II (2003) 338-341
63. Dumaine R., Towbin J.A., Brugada P., et al. Ionic mechanism responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 85 (1999) 803-809
64. Priori S.G., Napolitano C., Gasparini M., et al. Natural history of Brugada syndrome. Insights for risk stratification and management. Circulation 105 (2002) 1342-1347
65. Brugada P., Brugada R., Mont L., et al. Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart. J Cardiovasc Electrophysiol 14 (2003) 455-457
66. Sarkozy A., and Brugada P. Sudden cardiac death and inherited arrhythmia syndromes. J Cardiovasc Electrophysiol 16 suppl (2005) S8-S20
67. Consensus Statement of the Joint Steering Committees of UCARE and of IVF-US. Survivors of out-of-hospital cardiac arrest with apparently normal heart: Need for definition and standardized clinical evaluation. Circulation 95 (1997) 265-272
68. Leenhardt A., Glaser E., Burguera M., et al. Short coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular fibrillation. Circulation 89 (1994) 206-215
69. Leenhardt A., Lucet V., Denjoy I., et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7 year follow-up of 21 patients. Circulation 91 (1995) 1512-1519
70. Priori S.G., Napolitano C., Natascia T., et al. Mutations of the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103 (2001) 196-200
71. Krahn A.D., Gollob M., Yee R., et al. Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion. Circulation 112 (2005) 2228-2234
72. Krahn A.D., Manfreda J., and Tate R.B. The natural history of electrocardiographic preexcitation in men. The Manitoba follow-up study. Ann Intern Med 116 (1992) 456-460
73. Orejerana L.A., Vidaillet H.J., and DeStefano F. Population prevalence of Wolff-Parkinson-White syndrome. J Am Coll Cardiol (1995) abstr 327A
74. Fitzpatrick A.P., Gonzales R.P., Lesh M.D., et al. New algorithm for the localization of accessory atrioventricular connections using a baseline electrocardiogram. J Am Coll Cardiol 23 (1994) 107-116
75. Klein G.J., Prystowsky E.N., Yee R., et al. Asymptomatic Wolff-Parkinson-White. Should we intervene?. Circulation 80 (1989) 1902-1905
76. Klein G.J., Bashore T.M., Sellers T.D., et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med 301 (1979) 1080-1085
77. Pappone C., Santinelli V., Rosanio S., et al. Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White syndrome. J Am Coll Cardiol 41 (2003) 239-244
78. Levy S., and Broustedt J.P. Exercise testing in the Wolff-Parkinson-White syndrome. Am J Cardiol 48 (1981) 976-979